Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Int J Cancer. 2019 May 30;145(11):3152–3162. doi: 10.1002/ijc.32412

Figure 3. Prognostic molecular signatures for overall survival in OPSCC.

Figure 3.

(A) In HPV-positive OPSCC, the presence of NOTCH1 mutation predicts worse overall survival (OS). (B) In HPV-negative OPSCC, SOX2 amplification is associated with worse OS. (C) NOTCH1 mutations in OPSCC. Red arrows point to the mutations in HPV-P tumors.